Recommended Pages at manufacturing.pharmaceutical-business-review.com
Valeant Pharma to take over Afexa - Pharmaceutical Business Review
manufacturing.pharmaceutical-business-review.com — “Valeant Pharmaceuticals, a developer, manufacturer and marketer of a range of pharmaceutical products primarily in the areas of neurology, dermatology” View full resource at manufacturing.pharmaceutical-business-review.com
Most Recently Shared on August 31, 2011 at 12:01 pm By:
Valeant's buying Afexa, right out from under Paladin Labs' nose. $VRX CEO says OTC brands will add to consumer lineup http://t.co/KZX5LqZ
Astellas Pharma to transfer Intal rights to Sanofi-aventis - News - Manufacturing
manufacturing.pharmaceutical-business-review.com — “Astellas Pharma is set to transfer the rights to distribute the anti-allergic drug Intal (sodium cromoglycate) to Sanofi-aventis effective on 1 January 2011.” View full resource at manufacturing.pharmaceutical-business-review.com
Most Recently Shared on October 21, 2010 at 1:42 am By:
Michael Blaiss, MD Doctor, Allergist, and Physician
Astellas Pharma to transfer Intal rights to Sanofi-aventis - News - Manufacturing http://is.gd/gatRD
Stirling Pharma receives Site License for manufacturing facility in Canada - News - Manufacturing
manufacturing.pharmaceutical-business-review.com — “Stirling Pharma has received Site License from the Health Canada's Minister of Health under the authority of the Natural Health Products Regulations for the manufacturing, packaging and labelling of natural health products at its manufacturing facility located in North Sydney, Nova Scotia.” View full resource at manufacturing.pharmaceutical-business-review.com
Most Recently Shared on October 19, 2010 at 8:07 am By:
Natural Health News! Health News
Stirling Pharma receives Site License for manufacturing facility in Canada http://bit.ly/a6u4I9
